Thus, the link between MetS and cancer is becoming more evident, suggesting that the potential risk factors involved in the development of this process are obesity and T2DM, where the insulin-like growth factor-1 (IGF-1), alongside its intracellular signaling pathways, plays a key role in this kind of pathology [59]. Here, IGF1 is linked to cancer.